BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23933388)

  • 1. Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells.
    Seifert R
    Biochem Pharmacol; 2013 Oct; 86(7):853-61. PubMed ID: 23933388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for ligand-specific conformations of the histamine H(2)-receptor in human eosinophils and neutrophils.
    Reher TM; Brunskole I; Neumann D; Seifert R
    Biochem Pharmacol; 2012 Nov; 84(9):1174-85. PubMed ID: 22922404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the histamine H2-receptor in human monocytes.
    Werner K; Neumann D; Seifert R
    Biochem Pharmacol; 2014 Nov; 92(2):369-79. PubMed ID: 25199456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity.
    Brunskole Hummel I; Reinartz MT; Kälble S; Burhenne H; Schwede F; Buschauer A; Seifert R
    PLoS One; 2013; 8(5):e64556. PubMed ID: 23741338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
    Vaidehi N; Kenakin T
    Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution metabolic profiling towards G protein-coupled receptors: rapid and comprehensive screening of histamine H₄ receptor ligands.
    Kool J; Rudebeck AF; Fleurbaaij F; Nijmeijer S; Falck D; Smits RA; Vischer HF; Leurs R; Niessen WM
    J Chromatogr A; 2012 Oct; 1259():213-20. PubMed ID: 22520160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical stimulatory effects of the "standard" histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity.
    Seifert R; Schneider EH; Dove S; Brunskole I; Neumann D; Strasser A; Buschauer A
    Mol Pharmacol; 2011 Apr; 79(4):631-8. PubMed ID: 21266488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a novel bifunctional biogenic amine receptor by two point mutations of the H2-histamine receptor.
    DelValle J; Gantz I; Wang L; Guo YJ; Munzert G; Tashiro T; Konda Y; Yamada T
    Mol Med; 1995 Mar; 1(3):280-6. PubMed ID: 8529106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
    Schnell D; Burleigh K; Trick J; Seifert R
    J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.